- ►annals.org [PDF] EM Balk, J Lau, LC Goudas, HS Jordan, B … - Annals of internal medicine, 2003 - Am Coll Physicians Background: Statins reduce cardiovascular events to a greater extent than can be
explained by their effect on lipids. Several studies have attempted to elucidate
mechanisms by which statins reduce cardiovascular risk. Purpose: To ... Cited by 135 - Related articles - BL Direct - All 4 versions
HE Bays, EA Stein, AK Shah, DL Maccubbin, … - The American journal of cardiology, 2002 - Elsevier This study examined the effects of simvastatin on C-reactive protein (CRP) and
other inflammatory markers in study subjects with significant elevations in
triglyceride (TG) blood levels. CRP, vascular cellular adhesion molecule ... Cited by 28 - Related articles - All 7 versions
WF Riesen - Current Drug Therapy, 2006 - ingentaconnect.com Abstract: Statins are a diverse group of drugs, which share the ability to
inhibit HMG CoA reductase and thereby the conversion of acetoacetyl CoA to
mevalonate, the rate-limiting step in cholesterol biosynthesis. By ... Cited by 1 - Related articles - BL Direct
A Gottsäter, I Anwaar, P Lind, I Mattiasson, F … - Blood Coagulation & Fibrinolysis, 1999 - journals.lww.com Blood Coagulation and Fibrinolysis 1999, 10:133-140 Increasing plasma
fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma
endothelin-1, factor VII, and neopterin during cholesterol lowering with ... Cited by 34 - Related articles - BL Direct - All 4 versions
- ►bmj.com VG Athyros, DP Mikhailidis, AA Papageorgiou, … - British Medical Journal, 2004 - jcp.bmj.com Methods/Results: All patients had plasma creatinine values within the reference
range < 115 µmol/litre (13 mg/litre). The on study creatinine clearance (CrCl),
as estimated (for up to 48 months) by the Cockroft-Gault formula, was ... Cited by 180 - Related articles - BL Direct - All 8 versions
BMY Cheung, IJ Lauder, CP Lau, CR Kumana - British journal of clinical pharmacology, 2004 - pubmedcentral.nih.gov Ten trials involving 79 494 subjects were included in the meta-analysis. Due to
heterogeneity, ALLHAT-LLT was excluded from some analyses. Statin therapy
reduced major coronary events by 27% (95%CI 23, 30%), stroke by 18% (95%CI ... Cited by 153 - Related articles - BL Direct - All 6 versions
JA Gómez-Gerique, E Ros, J Oliván, JM … - Atherosclerosis, 2002 - Elsevier C-reactive protein (CRP) is a non-specific but sensitive marker of underlying
systemic inflammation. High CRP plasma levels correlate with risk for future
cardiovascular events. The present study evaluated the effects of ... Cited by 43 - Related articles - All 5 versions
- ►oxfordjournals.org A Asberg, A Hartmann, E Fjeldsa, H Holdaas - Nephrology Dialysis Transplantation, 2001 - ERA-EDTA Background. Hyperlipidaemia and endothelial dysfunction are common features in
cyclosporin A (CsA)-treated renal transplant recipients. Endothelial dysfunction
may contribute to the risk of premature atherosclerosis and cardiovascular ... Cited by 49 - Related articles - BL Direct - All 5 versions
KCB Tan, ED Janus, KSL Lam - The American journal of cardiology, 1999 - Elsevier Disturbances of the hemostatic system leading to thrombogenesis may enhance the
development of vascular damage and contribute to the pathogenesis of
atherosclerosis. Patients with type 2 diabetes mellitus have abnormalities ... Cited by 20 - Related articles - BL Direct - All 7 versions
